Case presentation: nephrolithiasis in a patient treated with atazanavir.
Of the recently approved antiretroviral protease inhibitors, atazanavir has become a popular medication for the treatment of HIV infection. The advantages of an atazanavir-based regimen include a favorable side effect profile, low impact on lipids, low pill burden, and daily dosing. These have made it a favorable choice for antiretroviral treatment. As more experience is gained with newer antiretroviral medications, additional side effects become apparent. Recent reports have highlighted occurrences of nephrolithiasis in patients using atazanavir-based regimens. The authors present a case of a patient who experienced nephrolithiasis while taking combination antiretroviral therapy that included atazanavir.
Savini
Carolyn
C
HIV Program at Christiana Care Health System in Delaware, USA.
James
Christopher
C
Wilson
Susan
S
Martin
Heather
H
Szabo
Susan
S
Scotto
Vincenzo
V
D000328:Adult; D000069446:Atazanavir Sulfate; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D053040:Nephrolithiasis / Q000139:chemically induced* / Q000150:complications; D009842:Oligopeptides / Q000009:adverse effects*; D011725:Pyridines / Q000009:adverse effects*
D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate